Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Conference Participants

doi:10.1016/j.kint.2018.10.018

Management and treatment of glomerular diseases (part 1)

Standard

Management and treatment of glomerular diseases (part 1) : conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. / Conference Participants.

in: KIDNEY INT, Jahrgang 95, Nr. 2, 02.2019, S. 268-280.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Conference Participants 2019, 'Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference', KIDNEY INT, Jg. 95, Nr. 2, S. 268-280. https://doi.org/10.1016/j.kint.2018.10.018

APA

Conference Participants (2019). Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. KIDNEY INT, 95(2), 268-280. https://doi.org/10.1016/j.kint.2018.10.018

Vancouver

Conference Participants. Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. KIDNEY INT. 2019 Feb;95(2):268-280. https://doi.org/10.1016/j.kint.2018.10.018

Bibtex

@article{144a9bd12caf4eeeabe83fdaa2b0c2c7,

title = "Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference",

abstract = "The Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a Controversies Conference on glomerular diseases in November 2017. The conference focused on the 2012 KDIGO guideline with the aim of identifying new insights into nomenclature, pathogenesis, diagnostic work-up, and, in particular, therapy of glomerular diseases since the guideline's publication. It was the consensus of the group that most guideline recommendations, in particular those dealing with therapy, will need to be revisited by the guideline-updating Work Group. This report covers general management of glomerular disease, IgA nephropathy, and membranous nephropathy.",

keywords = "Biopsy, Consensus Development Conferences as Topic, Disease Progression, Glomerular Filtration Rate, Glomerulonephritis, IGA/pathology, Glomerulonephritis, Membranous/pathology, Humans, Kidney Glomerulus/pathology, Nephrology/methods, Nephrosis, Lipoid, Practice Guidelines as Topic, Renal Insufficiency, Chronic/pathology, Risk Factors, Treatment Outcome",

author = "J{\"u}rgen Floege and Barbour, {Sean J} and Cattran, {Daniel C} and Hogan, {Jonathan J} and Nachman, {Patrick H} and Tang, {Sydney C W} and Wetzels, {Jack F M} and Michael Cheung and Wheeler, {David C} and Winkelmayer, {Wolfgang C} and Rovin, {Brad H} and {Conference Participants}",

year = "2019",

month = feb,

doi = "10.1016/j.kint.2018.10.018",

language = "English",

volume = "95",

pages = "268--280",

journal = "KIDNEY INT",

issn = "0085-2538",

publisher = "NATURE PUBLISHING GROUP",

number = "2",

}

RIS

TY - JOUR

T1 - Management and treatment of glomerular diseases (part 1)

T2 - conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

AU - Floege, Jürgen

AU - Barbour, Sean J

AU - Cattran, Daniel C

AU - Hogan, Jonathan J

AU - Nachman, Patrick H

AU - Tang, Sydney C W

AU - Wetzels, Jack F M

AU - Cheung, Michael

AU - Wheeler, David C

AU - Winkelmayer, Wolfgang C

AU - Rovin, Brad H

AU - Conference Participants

PY - 2019/2

Y1 - 2019/2

N2 - The Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a Controversies Conference on glomerular diseases in November 2017. The conference focused on the 2012 KDIGO guideline with the aim of identifying new insights into nomenclature, pathogenesis, diagnostic work-up, and, in particular, therapy of glomerular diseases since the guideline's publication. It was the consensus of the group that most guideline recommendations, in particular those dealing with therapy, will need to be revisited by the guideline-updating Work Group. This report covers general management of glomerular disease, IgA nephropathy, and membranous nephropathy.

AB - The Kidney Disease: Improving Global Outcomes (KDIGO) initiative organized a Controversies Conference on glomerular diseases in November 2017. The conference focused on the 2012 KDIGO guideline with the aim of identifying new insights into nomenclature, pathogenesis, diagnostic work-up, and, in particular, therapy of glomerular diseases since the guideline's publication. It was the consensus of the group that most guideline recommendations, in particular those dealing with therapy, will need to be revisited by the guideline-updating Work Group. This report covers general management of glomerular disease, IgA nephropathy, and membranous nephropathy.

KW - Biopsy

KW - Consensus Development Conferences as Topic

KW - Disease Progression

KW - Glomerular Filtration Rate

KW - Glomerulonephritis, IGA/pathology

KW - Glomerulonephritis, Membranous/pathology

KW - Humans

KW - Kidney Glomerulus/pathology

KW - Nephrology/methods

KW - Nephrosis, Lipoid

KW - Practice Guidelines as Topic

KW - Renal Insufficiency, Chronic/pathology

KW - Risk Factors

KW - Treatment Outcome

U2 - 10.1016/j.kint.2018.10.018

DO - 10.1016/j.kint.2018.10.018

M3 - SCORING: Journal article

C2 - 30665568

VL - 95

SP - 268

EP - 280

JO - KIDNEY INT

JF - KIDNEY INT

SN - 0085-2538

IS - 2

ER -